Translational and Actionable Data as a Service

Sometimes team's capabilities can't cover what your program needs. MIMETAS has generated data for pharmaceutical partners for more than a decade, using human-relevant organ models built to answer this specific need. Whether you are looking for a fast, standardized readout on a defined endpoint or a fully bespoke study built around a novel question, our scientists design and execute it in our laboratories.

Discuss your research needs

Two Ways to Work With Us

STANDARDIZED · FAST TURNAROUND

OrganoServices

A validated, off-the-shelf assay you can order directly. Ship your compounds, and receive a structured results report — typically within about a week of assay completion. No protocol development, no equipment, no in-house organ-on-a-chip expertise required. Now available for GI toxicity and DIVI.

Best for: Screening compounds quickly, investigating compound liabilities, or accessing organ-on-a-chip data for the first time.

Explore OrganoServices

Bespoke · Built around your program

Custom Services

A dedicated project team designs and runs a custom study around your specific biological question: modified protocols, additional endpoints, disease-specific models, or novel target validation. Our support ranges from early hypothesis testing and disease model development to pharmacology, IND-enabling studies, and the data packages needed to support clinical advancement.

Best for: Novel hypotheses, non-standard endpoints, or programs that need a tailored study design rather than a defined assay.

Explore custom services

Which Service Is Right for You?

Choose OrganoServices if you:

Need standardized data quickly (results in ~1 week after assay completion)

Don't have time, resources or organ-on-a-chip capabilities in-house

Want to evaluate compounds before committing further internal resources or moving to animal studies

Are working with a well-characterized safety concern (e.g. GI toxicity, DIVI) that fits an existing validated assay

Choose Custom Services if you:

Are entering a new disease mechanism or indication with no established assays

Need a modified protocol, additional endpoints, or a disease-specific model

Are validating a novel target or disease hypothesis

Want a dedicated scientific team involved in study design, not just execution

Introducing OrganoServices

OrganoServices is MIMETAS' standardized contract research offering: you provide the compound, we run the experiment on our OrganoReady® models under physiologically relevant microfluidic conditions. There's no equipment or protocol development on your end — just a structured report, typically within one week of assay completion, with all data and IP remaining exclusively yours.

Fast turnaround

Hands-off complex assays

Built on highly standardized OrganoReady® models

Explore OrganoServices